Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Mononuclear Leukocytes. Found 5 abstracts

Sariyer R, De-Simone FI, Gordon J, Sariyer IK. Immune suppression of JC virus gene expression is mediated by SRSF1. Journal of neurovirology. 2016 Oct;22(5):597-606.   PMCID: PMC5014737
Kogan M, Deshmane S, Sawaya BE, Gracely EJ, Khalili K, Rappaport J. Inhibition of NF-kappaB activity by HIV-1 Vpr is dependent on Vpr binding protein. Journal of cellular physiology. 2013 Apr;228(4):781-90.   PMCID: Pmc3604695
Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res. 2003 Apr;9(4):1517-27.
Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halberr T, Qian M, Gallo JM. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res. 2000 Aug;6(8):3071-80.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Mononuclear Leukocytes

metabolism Mononuclear Leukocytes genetics immunology Non-US Gov't Support Female Aged Human Male Adult Carrier Proteins Drug Dose-Response Relationship therapeutic use Middle Age blood biosynthesis Signal Transduction Interferon Type II antagonists & inhibitors Virus Replication Neoplasms US Gov't Support-PHS Enzyme-Linked Immunosorbent Assay T-Lymphocytes urine growth & development therapy Genetic Transcription Immune mediators HSP27 Heat-Shock Proteins physiology Srsf1 Synthetic Vaccines Treatment Outcome Dr Ilker K Sariyer reports no disclosures or conflicts of interest Gene Expression Regulation drug effects cytology Cultured Cells Biopsy Reactivation Immunotherapy adverse Regression Analysis Stable cells Neuroimmune interaction pharmacology Middle Aged I-kappa B Proteins methods Membrane Glycoproteins Tumor Necrosis Factor-alpha CD40 Ligand Oral Administration Adenocarcinoma Immunoglobulin G Cell Death adverse effects effects HIV Infections CD80 Antigens Colorectal Neoplasms MHC Class I Genes Phytogenic Antineoplastic Agents Cultured Tumor Cells Transcription JC virus Phenotype JC Virus Pml Human Immunodeficiency Virus vpr Gene Products Apoptosis Phagocytosis Ovarian Neoplasms Ultraviolet Rays Cancer Vaccines Carcinoembryonic Antigen Serine-Arginine Splicing Factors interest Dr Francesca I De-Simone reports no disclosures or conflicts of Fetus pharmacokinetics Avipoxvirus Small Interfering RNA toxicity Proto-Oncogene Protein p21(ras) NF-kappa B interest Dr Jennifer Gordon reports no disclosures or conflicts of interest secretion Replication drug therapy Neuroglia HIV-1 Host-Pathogen Interactions Primary Cell Culture Conditioned Culture Media Flow Cytometry Terpenes Tumor Cell Line Dendritic Cells Myeloid Cells Pilot Projects Drug Administration Schedule
Last updated on Thursday, April 02, 2020